Archive for the ‘Eye Health / Blindness’ Category
Tuesday, March 9th, 2010
Diabetic retinopathy, the leading cause of blindness in the UK's working-age population, could be associated with poorer memory and diminished brain power in people with Type 2 diabetes, according to new research¹ announced this week at leading health charity Diabetes UK's Annual Professional Conference. The study looked at 1,066 people with Type 2 diabetes aged between 60 and 75 years old...
Friday, March 5th, 2010
Diabetic retinopathy could be associated with poorer memory and diminished brain power in people with Type 2 diabetes, according to new research announced this week at Diabetes UK's Annual Professional Conference. The study looked at 1,066 people with Type 2 diabetes aged between 60 and 75 years...
Sunday, February 28th, 2010
On March 1, the first eye patients will enter an innovative new $132 million facility that expands the University of Michigan Health System's capacity for eye care, research and education, and unites diabetes researchers as they work to accelerate the search for a cure and prevention of diabetes. The Brehm Tower at the W.K...
Saturday, February 20th, 2010
Bayer HealthCare AG and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that VEGF Trap-Eye showed positive results in a Phase II study in patients with Diabetic Macular Edema (DME). The primary endpoint of the study, a statistically significant improvement in visual acuity over 24 weeks compared to the standard of care in DME, macular laser treatment, was met...
Friday, January 22nd, 2010
pSivida Corp. (NASDAQ:PSDV)(ASX:PVA)(FF:PV3), a leader in the development of tiny, sustained-release drug delivery technologies, with two of the only three ophthalmic sustained-release delivery products approved by the FDA for treatment of back of the eye diseases, announced that its chief executive officer, Dr...
Friday, January 15th, 2010
Many healthcare professionals are failing to advise people with medical conditions that could affect their ability to drive whether they should get behind the wheel, according to research from the University of Warwick...
Friday, January 15th, 2010
The discovery of an inflammatory mediator key to the blinding effects of diabetic retinopathy is pointing toward a potential new treatment, Medical College of Georgia researchers said...
Friday, January 8th, 2010
A research team led by a Michigan State University professor has discovered a link between diabetes and bone marrow nerve damage that may help treat one of the disease's most common and potentially blindness-causing complications...
Friday, January 8th, 2010
Scientists in Massachusetts are reporting new evidence that certain high blood pressure drugs may be useful in preventing and treating diabetic retinopathy, the leading cause of vision loss in people with diabetes. The study, the largest to date on proteins in the retina, could lead to new ways to prevent or treat the sight-threatening disease, they say...
Tuesday, January 5th, 2010
This month's Ophthalmology, the journal of the American Academy of Ophthalmology, includes a research review of the effects of Vitamins C and E and magnesium on diabetic retinopathy and findings from the first large study of vision problems in Hispanic and African-American infants and young children...
Wednesday, December 2nd, 2009
Can treatments that reduce risks for cardiovascular disease (CVD) also help combat age-related macular degeneration (AMD) , an eye disease that affects millions of Americans? CVD and AMD share some risk factors such as smoking, high blood pressure, and inflammation and a recent study found that people who have early-stage AMD are more likely to develop heart disease...
Friday, November 27th, 2009
New Molecule Implicated in Diabetes-Associated Blindness A group led by Dr. Jian-xing Ma at The University of Oklahoma Health Sciences Center, Oklahoma City, OK has demonstrated that the Wnt signaling pathway plays a role in diabetic retinopathy. Their report can be found in the December 2009 issue of The American Journal of Pathology...
Wednesday, November 11th, 2009
If you have diabetes, a dilated eye exam should be at the top of your yearly health care to-do list. Diabetic eye disease, also known as diabetic retinopathy, is the leading cause of vision loss in American adults. As part of November's Diabetic Eye Disease Awareness Month, ophthalmologists at the Glick Eye Institute at the Indiana University School of Medicine encourage diabetics and all at-risk adults to make eye care a priority.
Sunday, November 1st, 2009
Diabetes causes more new cases of legal blindness among working-age Americans than any other disease. If diabetics are monitored regularly by their ophthalmologist, this vision loss is almost always avoidable. Yet, tragically, more than half of all people living with diabetes do not get the recommended annual dilated eye exam. As the number of people with Type 2 diabetes rises in the U.S., the CDC projects that the number of adults with diabetic retinopathy will double by the year 2050.
Thursday, October 29th, 2009
This month's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy) reports on a national study that finds cataract surgery is likely to benefit patients with age-related macular degeneration (AMD) at all stages of the disease, on a clinical trial showing that the steroid triamcinolone may be effective in advanced diabetic macular edema (DME) patients when standard treatment fails, and on the public's use of two Academy-sponsored online eye health forums.
Monday, October 26th, 2009
Two studies are of particular note in theScientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO): a report by Swiss neuro-ophthalmic researchers about vision exam clues that should make ophthalmologists suspect an atypical variant of Alzheimer's disease; and new evidence from a Singapore National Eye Center study that diabetics who are nearsighted may be less susceptible to diabetic retinopathy.
Monday, October 26th, 2009
Two studies are of particular note in today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO): a report by Swiss neuro-ophthalmic researchers about vision exam clues that should make ophthalmolog
Thursday, October 22nd, 2009
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) announced poster presentations of results from the Company's Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies in allergic conjunctivitis. The studies demonstrated Bepreve was safe and well-tolerated when given twice daily for six weeks in a healthy pediatric population as young as three years of age.
Thursday, October 22nd, 2009
Eyetech Inc. announced the publication of data from a randomized, prospective, open-label study evaluating the investigational use of intravitreal Macugen® (pegaptanib sodium injection) compared to pan-retinal laser photocoagulation (PRP) in the treatment of active proliferative diabetic retinopathy (PDR). The article is available in the online edition of the British Journal of Ophthalmology (BJO) and scheduled for publication in the November 2009 issue.
Saturday, October 3rd, 2009
Highlights of October's Ophthalmology, the journal of the American Academy of Ophthalmology, include good news on preserving vision in people with type 1 diabetes, a warning from the Cardiovascular Health Study for macular degeneration patients, and a report on how vision impacts well-being across the lifespan.
Friday, October 2nd, 2009
Highlights of October's Ophthalmology, the journal of the American Academy of Ophthalmology, include good news on preserving vision in people with type 1 diabetes, a warning from the Cardiovascular Health Study for macular degeneration patients, and look at vision's impact on well-being across the lifespan.